Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange-Mass Spectrometry.
Hiroyuki KojimaRyota YanagiEri HiguchiMami YoshizawaTomoyuki ShimodairaMisaki KumagaiTatsuhiro KyoyaMiyu SekineDaichi EgawaNami OhashiHiroaki IsidaKeiko YamamotoToshimasa ItohPublished in: Journal of medicinal chemistry (2023)
Covalent ligands are generally filtered out of chemical libraries used for high-throughput screening, because electrophilic functional groups are considered to be pan-assay interference compounds (PAINS). Therefore, screening strategies that can distinguish true covalent ligands from PAINS are required. Hydrogen/deuterium-exchange mass spectrometry (HDX-MS) is a powerful tool for evaluating protein stability. Here, we report a covalent modifier screening approach using HDX-MS. In this study, HDX-MS was used to classify peroxisome proliferator-activated receptor γ (PPARγ) and vitamin D receptor ligands. HDX-MS could discriminate the strength of ligand-protein interactions. Our HDX-MS screening method identified LT175 and nTZDpa, which can bind concurrently to the PPARγ ligand-binding domain (PPARγ-LBD) with synergistic activation. Furthermore, iodoacetic acid was identified as a novel covalent modifier that stabilizes the PPARγ-LBD.
Keyphrases
- mass spectrometry
- liquid chromatography
- multiple sclerosis
- ms ms
- gas chromatography
- capillary electrophoresis
- insulin resistance
- high resolution
- high performance liquid chromatography
- fatty acid
- small molecule
- metabolic syndrome
- binding protein
- adipose tissue
- type diabetes
- magnetic resonance
- magnetic resonance imaging
- cancer therapy